Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OXER1 | Q8TDS5 | 11/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.33 |
| ▸ | THRA | P10827 | 2/20 | 0.32 |
| ▸ | THRB | P10828 | 2/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | MMP9 | P14780 | 1/20 | 0.32 |
| ▸ | MMP12 | P39900 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4214092 | 0.99 | GPR84 (0.35) | OXER1GPR84THRATHRBMMP2 | |
| SCHEMBL4204689 | 0.99 | GPR84 (0.35) | OXER1GPR84THRATHRBMMP2 | |
| SCHEMBL432625 | 0.99 | GPR84 (0.35) | OXER1GPR84THRATHRBMMP2 | |
| SCHEMBL3225427 | 0.92 | CYP1A2 (0.32) | — | |
| SCHEMBL2155760 | 0.82 | OXER1 (0.45) | OXER1MMP2MMP9MMP12 | |
| SCHEMBL8441354 | 0.82 | OXER1 (0.45) | OXER1GPR84 | |
| SCHEMBL15846668 | 0.81 | OXER1 (0.47) | OXER1GPR84 | |
| SCHEMBL3269501 | 0.81 | OXER1 (0.47) | OXER1GPR84 | |
| SCHEMBL432579 | 0.81 | OXER1 (0.47) | OXER1MMP2MMP9MMP12 | |
| SCHEMBL2540720 | 0.81 | OXER1 (0.47) | OXER1MMP2MMP9MMP12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230348385-A1 | POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE | BIOSYNTH AG (CH) | 2023-11-02 | — | — | US | claimed |
| EP-4196465-A1 | POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE | Biosynth AG (CH) | 2023-06-21 | — | — | EP | claimed |
| WO-2022038120-A1 | POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE | BIOSYNTH AG (CH) | 2022-02-24 | — | — | WO | claimed |
| US-20200298233-A1 | MICROFLUIDIC PAPER CHIP FOR DETECTING MICRO-ORGANISM, METHOD FOR PREPARING THE SAME AND METHOD FOR DETECTING MICRO-ORGANISM USING THE SAME | BIOMAX CO., LTD. (KR) | 2020-09-24 | — | — | US | claimed |
| EP-2588219-B1 | FILTER PLATE ARTICLE HAVING A WATER-ABSORBENT FILTER ASSEMBLY | NEOGEN FOOD SAFETY US HOLDCO CORP (US) | 2024-05-29 | — | — | EP | disclosed |
| US-20230348385-A1 | POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE | BIOSYNTH AG (CH) | 2023-11-02 | — | — | US | disclosed |
| US-20230348385-A1 | POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE | BIOSYNTH AG (CH) | 2023-11-02 | — | — | US | disclosed |
| EP-4196465-A1 | POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE | Biosynth AG (CH) | 2023-06-21 | — | — | EP | disclosed |
| EP-4196465-A1 | POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE | Biosynth AG (CH) | 2023-06-21 | — | — | EP | disclosed |
| WO-2022038120-A1 | POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE | BIOSYNTH AG (CH) | 2022-02-24 | — | — | WO | disclosed |
| WO-2022038120-A1 | POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE | BIOSYNTH AG (CH) | 2022-02-24 | — | — | WO | disclosed |
| US-11001873-B2 | Microorganism detection method comprising at least one alkyl(thio)glycoside | BIOMERIEUX (FR) | 2021-05-11 | — | — | US | disclosed |
| US-20080248518-A1 | E.coli and salmonella test kit | PATEL CHANDRAVADAN | 2008-10-09 | — | — | US | disclosed |
| US-20070020720-A1 | Method for the detection and/or identification of bacteria present in a sample | BIOMERIEUX (FR) | 2007-01-25 | — | — | US | disclosed |
| US-20060257966-A1 | Medium for detection and identification of micro-organisms | BIOMERIEUX (FR) | 2006-11-16 | — | — | US | disclosed |
| EP-1611246-A2 | MEDIUM FOR THE DETECTION AND IDENTIFICATION OF MICRO-ORGANISMS | BIOMERIEUX (FR) | 2006-01-04 | — | — | EP | disclosed |
| WO-2004092400-A2 | MEDIUM FOR THE DETECTION AND IDENTIFICATION OF MICRO-ORGANISMS | BIOMERIEUX (FR) | 2004-10-28 | — | — | WO | disclosed |
| US-6090541-A | Method and device for detecting bacteriophage using contrast-coloring and precipitable dyes | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-07-18 | — | — | US | disclosed |
| US-6004769-A | COMPOSITIONS AND PROCEDURES FOR THE DETERMINATION OF HYDROLYTIC ENZYMES IN LIQUID SAMPLES WITH THE AID OF INDOXYL COMPOUNDS AND OXIDIZING AGENTS | MERCK PATENT GESELLSCHAFT (DE) | 1999-12-21 | — | — | US | disclosed |
| US-5958675-A | Method for detecting bacteria using bacteriophage, contrast-coloring dye and precipitable dye | 3M INNOVATIVE PROPERTIES COMPANY (US) | 1999-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348385-A1 | POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE | IPO4, NCBP2, RCC1 | OXER1 3214/4885GPR84 4853/4885THRA 4559/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.